Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Featured insights

The latest at the Foundation

Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation.
Media

Poor countries desperately need better access to generic medicines

15 February 2023
Media

Here's how we can get better access to sexual and reproductive health to women around the world

02 February 2023
News

Index finds more pharma companies moving to address access to medicine. Will they now go further?

15 November 2022
Featured News

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023

Resource Center

Explore our research reports and publications
Featured Key findings

Some companies engaging in R&D for emerging infectious diseases, but pipeline mainly empty

15 November 2022
Key findings

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022
Featured News

Drugmakers that dominate the world's insulin market must scale up access efforts globally

06 October 2022
Research

Implementing strong access strategies across different country income classifications

15 November 2022
2022 Ranking

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

Read more
News

Drug makers must address access to antibiotics to help slow the superbug threat

09 June 2022
Event

Impact Summit Europe 2023: Marijn Verhoef to moderate session on healthcare systems and equitable access

28 March 2023
Media

Framework to assess, nudge generic drug makers to expand access to products

15 February 2023

Achievements so far

Read more about the Foundation's impact
Event

Closing the gaps in access to diabetes care in low- and middle-income countries

07 July 2022
News

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries

16 June 2021

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved